1. Administration of cycloheximide (an inhibitor of protein synthesis) to lactating rats raised the concentrations of amino acids, and in particular, the branched-chain amino acids (valine, leucine and isoleucine) 
1. Administration of cycloheximide (an inhibitor of protein synthesis) to lactating rats raised the concentrations of amino acids, and in particular, the branched-chain amino acids (valine, leucine and isoleucine) in blood, liver and mammary gland. 2. Inhibition of protein synthesis increased the incorporation in vivo of L-[U-'4Clleucine into lipids of mammary gland and liver. 3. Cycloheximide treatment caused no immediate change in the overall rate of lipogenesis in vivo (measured with 3H20) in mammary gland but increased the rate in liver 3-fold; this latter effect also occurred in livers of virgin rats. 4. The increased rate of hepatic lipogenesis was not accompanied by significant changes in the plasma insulin concentration or the activity of acetyl-CoA carboxylase. 5. Although cycloheximide decreased the entry of total triacylglycerol into the circulation it did not alter the rate of secretion of newly synthesized saponifiable lipid. 6. Cycloheximide slightly stimulated lipogenesis from endogenous substrates in isolated hepatocytes, but this effect was abolished when lactate was the exogenous substrate. 7. Administration of cycloheximide to virgin rats decreased liver glycogen and increased the hepatic content of glucose 6-phosphate, pyruvate and lactate. 8. It is concluded that (a) there is no short-term link between the rate of protein synthesis and lipogenesis in the lactating mammary gland and (b) the increased rate of hepatic lipogenesis in cycloheximidetreated rats is mainly due to stimulation consequent increased availability of pyruvate.
During lactation the mammary gland of the rat is a major site of utilization of substrates present in the circulation, for example, glucose for lipogenesis (Hawkins & Williamson, 1972; Robinson & Williamson, 1977) and amino acids for protein synthesis (Vfina & Williamson, 198 1b) . Recent experiments (Vinfa & Williamson, 198 la, b) have shown that certain amino acids, in particular L-leucine, can provide carbon for the formation of lipid in the gland as well as being incorporated into protein.
The original aim of the studies reported here was to examine whether inhibition of protein synthesis with cycloheximide leads to (198 la) .
The rate of lipogenesis in mammary gland and liver in vivo was measured by the incorporation of 3H20 into saponified lipid essentially by the method of Stansbie et al. (1976) with the modifications described by Robinson et al. (1978) .
The rate of triacylglycerol entry into the circulation was measured by a modification of the procedure of Otway & Robinson (1967) using Triton WR1339 to prevent triacylglycerol removal from the plasma (Scanu, 1965) . The modification consisted of the simultaneous administration of 3H20 to measure the rate of entry into the circulation of lipid synthesized de novo as well as triacylglycerols arising from esterification of fatty acids derived from adipose tissue or dietary fat (for details, see Agius et al., 1981) .
Liver and mammary-gland metabolites were determined by removal of a piece of tissue (about 2 g) from an anaesthetized rat and clamping it between light-alloy tongs cooled in liquid N2 (Wollenberger et al., 1960 ). The frozen tissue was then treated as described by Robinson & Williamson (1977) and the metabolites determined in the neutralized tissue extract.
Milk production (transfer to pups) was measured by removing the pups for 3 h and then returning to their mothers for 1 h. The litters were weighed just before recommencement of suckling and then again 1 h later; the difference in weight gives an indication of the amount of milk transferred (Cowie & Folley, 1947) .
Studies in vitro. Preparation of isolated hepatocytes. These were prepared from fed rats essentially by the method of Berry & Friend (1969) as modified by Krebs et al. (1974) .
Incubation procedure. Hepatocytes (60-90mg wet wt.) were incubated with constant shaking for 20, 40 and 60min in 4.0ml of Krebs-Henseleit (1932) (Keppler & Decker, 1974) ; glucose (Slein, 1963) ; glucose 6-phosphate (Lamprecht & Trautschold, 1963) ; L-lactate and pyruvate (Hohorst et al., 1959) ; citrate (Dagley, 1963) ; 2-oxoglutarate (Bergmeyer & Bernt, 1963) ; phosphoenolpyruvate, 2-phosphoglycerate and 3-phosphoglycerate (Czok & Eckert, 1963) . Whole blood and tissue amino acids were determined with an amino acid analyser (Jeol, model JLC-6AH).
Determination of hepatic acetyl-CoA carboxylase activity. For the determination of acetyl-CoA carboxylase activity freeze-clamped liver was powdered and homogenized by hand in 0.3 M-mannitol/ 50mM-Tris/acetate/2mM-EDTA, pH 7.4. The activity was determined in the supernatant after centrifugation in an Eppendorf centrifuge at 12000rev./min for 0.5 min by measuring the incorporation of [14C]bicarbonate into acid-stable material at 300C for 1.5 min (Majerus et al., 1968; Halestrap & Denton, 1973) . The assay incubation routinely contained 100mM-Tris/acetate, pH 7.4, 0.5 mM-EDTA, 10mg of defatted bovine serum albumin/ml, 1mM-glutathione, 20mM-magnesium acetate, 0.3mM-acetyl-CoA, 5mM-ATP, 20mM-NaH14C03. Samples of homogenate were assayed immediately for 'initial' activity in the presence and absence of 20mM-sodium citrate. A further sample was assayed for 'total' activity after a 30min pre-incubation at 300C in the presence of 20mM-sodium citrate. Reaction blanks containing no acetyl-CoA were also performed. One unit of enzyme activity represents lumol of substrate converted/min at 300 C.
Determination of insulin. Arterial blood was collected from the abdominal aorta into heparinized tubes. Plasma was separated by centrifugation at 3000rev./min for 10min. Plasma insulin was measured by radioimmunoassay with charcoal phase separation as described by Albano et al. (1972) .
Measurements of radioactivity. These were carried out as described by Williamson et al. (1975 Results and discussion Effects of cycloheximide on metabolism of L-leucine in vivo Injection of cycloheximide (2mg/kg body wt.) into fed lactating rats resulted in increased concentrations of virtually all amino acids present in blood, liver and mammary gland (results not shown). The changes in the concentration of the branched-chain amino acids valine, leucine and isoleucine are given in Table 1 . The increase in leucine concentration was 2.5-fold in blood and liver, and 9-fold in mammary gland. These increases in the tissue amino acid pools are presumably due to the inhibition of protein synthesis. As expected, cycloheximide (administered 1h before the radioactive tracer) decreased the incorporation of L-[U-14C]-leucine into proteins in both mammary gland and liver ( Effects ofcycloheximide on lipigenesis in vivo Lipogenesis was measured in vivo in liver and mammary gland of lactating rats with 3H20 to examine whether inhibition of protein synthesis altered the overall rate of this process. In mammary gland there was no significant change in the rate of 3H20 incorporation into saponified lipid for at least 120min after administration of cycloheximide; between 180 and 240min the rate declined to about 20% of control values (Table 3 ). This decline may be due to loss of enzyme activity secondary to the Table 1 . Effects of cycloheximide on concentrations of branched-chain amino acids in liver and mammary gland of lactating rats For details see the Experimental section. The rats were killed 2h after injection of cycloheximide (2 mg/kg body wt.)
or an equivalent volume of 0.9% NaCl. The results are means ± S.D. of three rats and are expressed as pmol/g of fresh tissue or umol/ml of whole blood. Values for cycloheximide-treated rats that are significantly different from the control rats by Student's t test are shown: *P < 0.05; **P < 0.005. (Agius et al., 1981) . This procedure allows simultaneous measurement of the entry of total triacylglycerol and also of that synthesized de novo. Triacylglycerol entry in control rats was virtually linear between 1 and 4 h, whereas in cycloheximide-treated rats the rate of entry decreased significantly (P<0.05) between 2 and 3h after administration of the cycloheximide (Fig. 1) . There was, 180-240min 118+45.9 (3) 20.6 + 4.7** (4) however, no significant difference between the rate of appearance of 3H20 in saponified plasma lipids between control and cycloheximide-treated rats (Fig.  2) . This latter result suggests that the apparent higher incorporation of 3H20 into saponified lipids of livers of cycloheximide-treated rats is not merely due to inhibition of secretion of the newly synthesized lipid. Further evidence in support of this conclusion is that little 3H-labelled lipid is/secreted within 60min in control rats (Fig. 2) and therefore measurements in liver over this period of time can be taken to indicate the rate of hepatic lipogenesis. Cycloheximide and acetyl-CoA carboxylase activity Two factors that might lead to a stimulation of hepatic lipogenesis are an increase in plasma insulin and/or an increase in the activation state of acetyl-CoA carboxylase (Stansbie et al., 1976) . Cycloheximide caused no significant increase in plasma insulin in either virgin or lactating rats (Table 4 ). There was, however, a significant decrease in blood glucose in both groups of rats after cycloheximide administration (Table 4 ). There was no significant alteration in the 'initial' or total activity of acetyl-CoA carboxylase in livers of lactating or virgin rats treated with cycloheximide (Table 5) . Cycloheximide and lipogenesis in isolated hepatocytes
To test the effects of cycloheximide on lipogenesis in vitro hepatocytes were isolated from control or cycloheximide-treated virgin rats and incubated in a medium containing 3H20. Addition of cycloheximide (20juM) caused a small but significant (P <0.05) increase in the rate of lipogenesis from endogenous substrates (mainly glycogen) in hepatocytes from control and cycloheximide-treated rats (Table 6 ). Addition of lactate (10mM) as exogenous substrate increased the rate of lipogenesis (80 and 160% respectively), but cycloheximide no longer stimulated the process (Table 6 ). The absence of an effect of cycloheximide when lipogenesis is not limited by the supply of substrate (on addition of lactate) is analogous to the findings with two hormones, vasopressin and insulin, which only stimulate lipogenesis when the rate of the process is submaximal (Assimacopoulos-Jeannet et al., 1981) . Vasopressin stimulates glycolysis (Hue et al., 1981; Assimacopoulos-Jeannet et al., 1981) and the effects of cycloheximide on hepatic lipogenesis could be explained if it also increased glycolytic flux. Cycloheximide and hepatic metabolites in vivo It has been reported that administration of cycloheximide to fed rats activates phosphorylase and depletes liver glycogen (Cecil & Bitman, 1966;  Wititsuwannakul & Kim (1978) found that cycloheximide increased cyclic AMP in rat liver slices and considered that this was responsible for the activation of phosphorylase. It is well-established that in rat liver cyclic AMP inhibits glycolysis (Harris, 1975) and lipogenesis (Capuzzi et al., 1974; Harris, 1975) and therefore cycloheximide must be able to overcome the inhibitory action of cyclic AMP. (Wititsuwannakul & Kim, 1978) . It is also of interest that the increase in the rate of lipogenesis apparently occurs without any change in the state of activation of acetyl-CoA carboxylase.
